{"type":"img","src":"https://cdn.quv.kr/dftb6ow8k%2Fup%2F5c32ea85dae40_1920.png","height":90}
  • COMPANY
  • R&D PIPELINE
  • CRO SERVICES
  • CAREER
  • NEWS
  • CONTACT US
  • {"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Noto Sans KR","Nanum Barun Gothic"]}
    ×
    섹션 설정
    {"type":"img","src":"https://cdn.quv.kr/dftb6ow8k%2Fup%2F5c32ea85dae40_1920.png","height":50}
  • COMPANY
  • R&D PIPELINE
  • CRO SERVICES
  • CAREER
  • NEWS
  • CONTACT US
  • NEWS

    RUDACURE

    NoticeBreaking into the global pharmaceutical market
    05-23
    Press releasesRudaCure at ARVO 2022
    05-23
    Academic JournalsInvestigating the Anti-Inflammatory Effects of RCI001 for Treating Ocular Surface Diseases: Insight
    05-23
    Press releasesRudaCure to present RCI001 pre-clinical data at ARVO 2022
    05-23
    Press releasesKIC Washington DC Mass Challenge helping RudaCure enter the US market
    05-23
    Press releases그 아픔까지 사랑할 거야 (I would even love the pain)
    05-23
    Academic JournalsComparison of therapeutic effects between topical 8-oxo-2'-deoxyguanosine and corticosteroid in ocul
    05-23
    IRRudaCure's Participation in 2022 JPM Health Care Conference
    05-23
    Press releasesDifferences between noteworthy companies in 2021 and K-Bio
    05-23
    Press releasesRudaCure’s Prof. Kim Dong Hyun, award winner in 2021 Korea Cornea Society’s Film Festival
    05-23
    CATEGORYTITLEDATE
    Introduction to the press
    TEST 12345678
    2시간 전

    글쓰기

    {"google":["Noto Sans"],"custom":["Nanum Square","Noto Sans KR"]}{"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Nanum Barun Gothic","Noto Sans KR","Jeju Gothic"]}
    {"google":[],"custom":["Noto Sans KR","Jeju Gothic"]}